Crescent Capital BDC, Inc. (CCAP)
| Market Cap | 527.39M |
| Revenue (ttm) | 189.13M |
| Net Income (ttm) | 49.55M |
| Shares Out | 37.06M |
| EPS (ttm) | 1.34 |
| PE Ratio | 10.64 |
| Forward PE | 7.88 |
| Dividend | $1.99 (13.99%) |
| Ex-Dividend Date | Jun 30, 2025 |
| Volume | 373,730 |
| Open | 14.11 |
| Previous Close | 14.10 |
| Day's Range | 13.97 - 14.25 |
| 52-Week Range | 13.54 - 20.19 |
| Beta | 0.60 |
| Analysts | Buy |
| Price Target | 17.60 (+23.68%) |
| Earnings Date | Aug 11, 2025 |
About CCAP
Crescent Capital BDC, Inc. is as a business development company is a private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States. [Read more]
Financial Performance
In 2024, Crescent Capital BDC's revenue was $197.36 million, an increase of 7.18% compared to the previous year's $184.13 million. Earnings were $73.65 million, a decrease of -12.15%.
Financial StatementsAnalyst Summary
According to 5 analysts, the average rating for CCAP stock is "Buy." The 12-month stock price target is $17.6, which is an increase of 23.68% from the latest price.
News
Private Equity For The People: 3 High-Yield BDCs Yielding Up To 13%
Let's invest like private equity pros without needing seven figures. Yes, that's right—PE-style starting for as little as $8.
2 BDCs With 20%+ Discounts, 1 To Buy And 1 To Avoid
BDCs have entered a challenging period. This is why the market has assigned notable discounts across the board. Some BDCs have become very deeply discounted.
Crescent Capital: 11% Yield And Fire Sale Price Make It A Buy
Crescent Capital BDC offers a compelling 10.9% dividend yield and trades at a 22% discount to NAV, providing a strong margin of safety. Recent headwinds, including lower NII and some non-accruals, are...
Crescent Capital BDC: NAV Decline Continues Following Q1 Earnings
Crescent Capital BDC trades at a significant discount to NAV and offers a high 12.5% yield, but recent performance and total returns have been weak. Rising non-accruals, declining earnings, and weaken...
Crescent Capital BDC: Latest Quarter A Clear Sign Of A Weakening Economy (Rating Downgrade)
I'm downgrading Crescent Capital from buy to hold due to weakening fundamentals and rising economic uncertainty. Recent earnings showed sequential declines in total and net investment income, with inc...
Crescent Capital BDC, Inc. (CCAP) Q1 2025 Earnings Conference Call Transcript
Crescent Capital BDC, Inc. (NASDAQ:CCAP) Q1 2025 - Earnings Conference Call May 15, 2025 12:00 PM ET Company Participants Dan McMahon - Head, IR Jason Breaux - CEO Henry Chung - President Gerhard Lom...
Crescent Capital BDC, Inc. Reports First Quarter 2025 Earnings Results; Declares a Second Quarter Base Dividend of $0.42 Per Share
LOS ANGELES, May 14, 2025 (GLOBE NEWSWIRE) -- Crescent Capital BDC, Inc. (“Crescent BDC” or “Company”) (NASDAQ: CCAP) today reported net investment income of $0.45 per share and net income of $0.11 pe...
My Income Portfolio: In The Garden Of Eden
Total Return can be misleading if not supported by NAV growth, as it may include unsustainable distributions and Return of Capital. Behavioral finance shows markets are irrational, making it crucial t...
Crescent Capital Group Appoints Jason Breaux as Head of Private Credit
LOS ANGELES--(BUSINESS WIRE)--Crescent Capital Group LP, a leading alternative credit investment firm, announced today the appointment of Jason Breaux as Head of Private Credit. In this role, Mr. Brea...
Crescent Capital BDC, Inc. Schedules Earnings Release and Conference Call to Discuss its First Quarter Ended March 31, 2025 Financial Results
LOS ANGELES, April 22, 2025 (GLOBE NEWSWIRE) -- Crescent Capital BDC, Inc. (“Crescent BDC”) (NASDAQ: CCAP) today announced it will release its financial results for the first quarter ended March 31, 2...
I'm Buying 2 Income Machines With 5-12% Yields
Spring is an ideal time for income investors to revisit portfolios, focusing on quality stocks like Crescent Capital BDC and Federal Realty Trust. Crescent Capital BDC offers a 12.4% yield, strong div...
Crescent Capital BDC: Solid Dividend Coverage Supports Return Potential
CCAP experienced a stock price drop of over 10% due to uncertainty about its income potential and value proposition. CCAP's portfolio is 90% first-lien debt, with 85% in non-cyclical industries, ensur...
Crescent Capital BDC: 11% Yield And 11% Discount Make It A Buy
Crescent Capital BDC, Inc. offers a 10.6% dividend yield and trades at an 11% discount to book value, making it a compelling income investment. CCAP's portfolio is conservatively managed with 90% seni...
My Income Portfolio: Financial Awareness
The essence of financial awareness is to realize that money can work for us through our investments. Understanding the value of money is the first step toward financial education, which leads to the s...
Crescent Capital BDC: Q4 Earnings Showing Signs Of Weakness (Rating Downgrade)
Crescent Capital BDC is downgraded due to a declining NII, and a less attractive discount to NAV. However, I don't see a reason for existing shareholders to sell. Despite recent weaknesses, CCAP maint...
I'm Buying Magnificent Dividends Up To 9% Yield
A contrarian mindset can help dividend investors find bargains, with Crescent Capital BDC and Cenovus Energy offering high yields after recent price drops. Crescent Capital BDC carries a diversified d...
Crescent Capital BDC, Inc. (CCAP) Q4 2024 Earnings Conference Call Transcript
Crescent Capital BDC, Inc. (NASDAQ:CCAP) Q4 2024 Earnings Conference Call February 20, 2025 ET Company Participants Dan McMahon - Head, IR Jason Breaux - CEO Henry Chung - President Gerhard Lombard -...
Crescent Capital BDC, Inc. Reports Fourth Quarter 2024 Earnings Results; Declares a First Quarter Base Dividend of $0.42 Per Share and Series of Special Dividends
LOS ANGELES, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Crescent Capital BDC, Inc. (“Crescent BDC” or “Company”) (NASDAQ: CCAP) today reported net investment income of $2.40 per share and net income of $1.99 p...
Yield Hunting Part 8: 7%+ In 1 Year From Crescent Capital BDC Baby Bonds
Crescent Capital BDC focuses on originating and investing in the debt of private middle-market U.S. companies, aiming for income and capital appreciation. The 5% baby bond FCRX trades at $24.54 with a...
Crescent Capital BDC, Inc. Schedules Earnings Release and Conference Call to Discuss its Fourth Quarter and Fiscal Year Ended December 31, 2024 Financial Results
LOS ANGELES, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Crescent Capital BDC, Inc. (“Crescent BDC”) (NASDAQ: CCAP) today announced it will release its financial results for the fourth quarter and fiscal year e...
My 9.5% Income Portfolio-Like Mosaic Tiles
Our investments, usually conceived and implemented gradually over time, are the pieces of a personal mosaic that form the whole of our assets. One solution for entering the financial markets can be Do...
Crescent Capital BDC: High Dividend Yield Looks Solid
Crescent Capital BDC, Inc. offers a solid dividend yield of around 8.6%, with strong dividend coverage that has led to specials being fairly regular. CCAP's portfolio is around 90% first-lien investme...
Crescent Capital: Share Price Finally Catching Up To Fundamentals
Crescent Capital BDC has shown strong price performance, solid financial growth, and high credit quality, making it a fundamentally sound buy despite a challenging economic backdrop. The BDC out-earne...
My 9.5% Income Portfolio: Better With Less, But Better
Risk is the probability of a negative event in the future. An abstract concept that is not measurable; otherwise it would not be risk. Ascertaining value is the first step in controlling risk, that is...